Global Bioresorbable Drug-Eluting Stents Market Research Report 2024(Status and Outlook)
Report Overview:
The bioabsorbable drug-eluting stent consists of a stent and a delivery system. The stent consists of three parts: a stent matrix, a developing marker, and a drug carrier coating. It is used to treat intravascular stenosis in patients with primary coronary atherosclerosis, improve coronary blood flow and prevent restenosis.
The Global Bioresorbable Drug-Eluting Stents Market Size was estimated at USD 192.05 million in 2023 and is projected to reach USD 385.21 million by 2029, exhibiting a CAGR of 12.30% during the forecast period.
This report provides a deep insight into the global Bioresorbable Drug-Eluting Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bioresorbable Drug-Eluting Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bioresorbable Drug-Eluting Stents market in any manner.
Global Bioresorbable Drug-Eluting Stents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Boston Scientific
Biotronik
Shanghai Bioheart Biological Technology
LifeTech Scientific
Lepu Medical Technology
Microport
Shandong Huaan Biotechnology
Shenzhen Salubris Biomedical Engineering
Beijing Advanced Medical Technologies
Market Segmentation (by Type)
Metal Base Stent
Polymer Stent
Market Segmentation (by Application)
Hospital
Specialty Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bioresorbable Drug-Eluting Stents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The bioabsorbable drug-eluting stent consists of a stent and a delivery system. The stent consists of three parts: a stent matrix, a developing marker, and a drug carrier coating. It is used to treat intravascular stenosis in patients with primary coronary atherosclerosis, improve coronary blood flow and prevent restenosis.
The Global Bioresorbable Drug-Eluting Stents Market Size was estimated at USD 192.05 million in 2023 and is projected to reach USD 385.21 million by 2029, exhibiting a CAGR of 12.30% during the forecast period.
This report provides a deep insight into the global Bioresorbable Drug-Eluting Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bioresorbable Drug-Eluting Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bioresorbable Drug-Eluting Stents market in any manner.
Global Bioresorbable Drug-Eluting Stents Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Boston Scientific
Biotronik
Shanghai Bioheart Biological Technology
LifeTech Scientific
Lepu Medical Technology
Microport
Shandong Huaan Biotechnology
Shenzhen Salubris Biomedical Engineering
Beijing Advanced Medical Technologies
Market Segmentation (by Type)
Metal Base Stent
Polymer Stent
Market Segmentation (by Application)
Hospital
Specialty Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Bioresorbable Drug-Eluting Stents Market
- Overview of the regional outlook of the Bioresorbable Drug-Eluting Stents Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bioresorbable Drug-Eluting Stents Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Bioresorbable Drug-Eluting Stents
1.2 Key Market Segments
1.2.1 Bioresorbable Drug-Eluting Stents Segment by Type
1.2.2 Bioresorbable Drug-Eluting Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIORESORBABLE DRUG-ELUTING STENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Bioresorbable Drug-Eluting Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bioresorbable Drug-Eluting Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIORESORBABLE DRUG-ELUTING STENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Bioresorbable Drug-Eluting Stents Sales by Manufacturers (2019-2024)
3.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bioresorbable Drug-Eluting Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bioresorbable Drug-Eluting Stents Sales Sites, Area Served, Product Type
3.6 Bioresorbable Drug-Eluting Stents Market Competitive Situation and Trends
3.6.1 Bioresorbable Drug-Eluting Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bioresorbable Drug-Eluting Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIORESORBABLE DRUG-ELUTING STENTS INDUSTRY CHAIN ANALYSIS
4.1 Bioresorbable Drug-Eluting Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIORESORBABLE DRUG-ELUTING STENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIORESORBABLE DRUG-ELUTING STENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2019-2024)
6.3 Global Bioresorbable Drug-Eluting Stents Market Size Market Share by Type (2019-2024)
6.4 Global Bioresorbable Drug-Eluting Stents Price by Type (2019-2024)
7 BIORESORBABLE DRUG-ELUTING STENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bioresorbable Drug-Eluting Stents Market Sales by Application (2019-2024)
7.3 Global Bioresorbable Drug-Eluting Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Bioresorbable Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
8 BIORESORBABLE DRUG-ELUTING STENTS MARKET SEGMENTATION BY REGION
8.1 Global Bioresorbable Drug-Eluting Stents Sales by Region
8.1.1 Global Bioresorbable Drug-Eluting Stents Sales by Region
8.1.2 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Bioresorbable Drug-Eluting Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bioresorbable Drug-Eluting Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bioresorbable Drug-Eluting Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Bioresorbable Drug-Eluting Stents Basic Information
9.1.2 Abbott Bioresorbable Drug-Eluting Stents Product Overview
9.1.3 Abbott Bioresorbable Drug-Eluting Stents Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Bioresorbable Drug-Eluting Stents SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Boston Scientific
9.2.1 Boston Scientific Bioresorbable Drug-Eluting Stents Basic Information
9.2.2 Boston Scientific Bioresorbable Drug-Eluting Stents Product Overview
9.2.3 Boston Scientific Bioresorbable Drug-Eluting Stents Product Market Performance
9.2.4 Boston Scientific Business Overview
9.2.5 Boston Scientific Bioresorbable Drug-Eluting Stents SWOT Analysis
9.2.6 Boston Scientific Recent Developments
9.3 Biotronik
9.3.1 Biotronik Bioresorbable Drug-Eluting Stents Basic Information
9.3.2 Biotronik Bioresorbable Drug-Eluting Stents Product Overview
9.3.3 Biotronik Bioresorbable Drug-Eluting Stents Product Market Performance
9.3.4 Biotronik Bioresorbable Drug-Eluting Stents SWOT Analysis
9.3.5 Biotronik Business Overview
9.3.6 Biotronik Recent Developments
9.4 Shanghai Bioheart Biological Technology
9.4.1 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Basic Information
9.4.2 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Overview
9.4.3 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Market Performance
9.4.4 Shanghai Bioheart Biological Technology Business Overview
9.4.5 Shanghai Bioheart Biological Technology Recent Developments
9.5 LifeTech Scientific
9.5.1 LifeTech Scientific Bioresorbable Drug-Eluting Stents Basic Information
9.5.2 LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Overview
9.5.3 LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Market Performance
9.5.4 LifeTech Scientific Business Overview
9.5.5 LifeTech Scientific Recent Developments
9.6 Lepu Medical Technology
9.6.1 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Basic Information
9.6.2 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Overview
9.6.3 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Market Performance
9.6.4 Lepu Medical Technology Business Overview
9.6.5 Lepu Medical Technology Recent Developments
9.7 Microport
9.7.1 Microport Bioresorbable Drug-Eluting Stents Basic Information
9.7.2 Microport Bioresorbable Drug-Eluting Stents Product Overview
9.7.3 Microport Bioresorbable Drug-Eluting Stents Product Market Performance
9.7.4 Microport Business Overview
9.7.5 Microport Recent Developments
9.8 Shandong Huaan Biotechnology
9.8.1 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Basic Information
9.8.2 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Overview
9.8.3 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Market Performance
9.8.4 Shandong Huaan Biotechnology Business Overview
9.8.5 Shandong Huaan Biotechnology Recent Developments
9.9 Shenzhen Salubris Biomedical Engineering
9.9.1 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Basic Information
9.9.2 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Overview
9.9.3 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Market Performance
9.9.4 Shenzhen Salubris Biomedical Engineering Business Overview
9.9.5 Shenzhen Salubris Biomedical Engineering Recent Developments
9.10 Beijing Advanced Medical Technologies
9.10.1 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Basic Information
9.10.2 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Overview
9.10.3 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Market Performance
9.10.4 Beijing Advanced Medical Technologies Business Overview
9.10.5 Beijing Advanced Medical Technologies Recent Developments
10 BIORESORBABLE DRUG-ELUTING STENTS MARKET FORECAST BY REGION
10.1 Global Bioresorbable Drug-Eluting Stents Market Size Forecast
10.2 Global Bioresorbable Drug-Eluting Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bioresorbable Drug-Eluting Stents Market Size Forecast by Country
10.2.3 Asia Pacific Bioresorbable Drug-Eluting Stents Market Size Forecast by Region
10.2.4 South America Bioresorbable Drug-Eluting Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bioresorbable Drug-Eluting Stents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Bioresorbable Drug-Eluting Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bioresorbable Drug-Eluting Stents by Type (2025-2030)
11.1.2 Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bioresorbable Drug-Eluting Stents by Type (2025-2030)
11.2 Global Bioresorbable Drug-Eluting Stents Market Forecast by Application (2025-2030)
11.2.1 Global Bioresorbable Drug-Eluting Stents Sales (K Units) Forecast by Application
11.2.2 Global Bioresorbable Drug-Eluting Stents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Bioresorbable Drug-Eluting Stents
1.2 Key Market Segments
1.2.1 Bioresorbable Drug-Eluting Stents Segment by Type
1.2.2 Bioresorbable Drug-Eluting Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIORESORBABLE DRUG-ELUTING STENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Bioresorbable Drug-Eluting Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bioresorbable Drug-Eluting Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIORESORBABLE DRUG-ELUTING STENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Bioresorbable Drug-Eluting Stents Sales by Manufacturers (2019-2024)
3.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bioresorbable Drug-Eluting Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bioresorbable Drug-Eluting Stents Sales Sites, Area Served, Product Type
3.6 Bioresorbable Drug-Eluting Stents Market Competitive Situation and Trends
3.6.1 Bioresorbable Drug-Eluting Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bioresorbable Drug-Eluting Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIORESORBABLE DRUG-ELUTING STENTS INDUSTRY CHAIN ANALYSIS
4.1 Bioresorbable Drug-Eluting Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIORESORBABLE DRUG-ELUTING STENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIORESORBABLE DRUG-ELUTING STENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2019-2024)
6.3 Global Bioresorbable Drug-Eluting Stents Market Size Market Share by Type (2019-2024)
6.4 Global Bioresorbable Drug-Eluting Stents Price by Type (2019-2024)
7 BIORESORBABLE DRUG-ELUTING STENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bioresorbable Drug-Eluting Stents Market Sales by Application (2019-2024)
7.3 Global Bioresorbable Drug-Eluting Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Bioresorbable Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
8 BIORESORBABLE DRUG-ELUTING STENTS MARKET SEGMENTATION BY REGION
8.1 Global Bioresorbable Drug-Eluting Stents Sales by Region
8.1.1 Global Bioresorbable Drug-Eluting Stents Sales by Region
8.1.2 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Bioresorbable Drug-Eluting Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bioresorbable Drug-Eluting Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bioresorbable Drug-Eluting Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Bioresorbable Drug-Eluting Stents Basic Information
9.1.2 Abbott Bioresorbable Drug-Eluting Stents Product Overview
9.1.3 Abbott Bioresorbable Drug-Eluting Stents Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Bioresorbable Drug-Eluting Stents SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Boston Scientific
9.2.1 Boston Scientific Bioresorbable Drug-Eluting Stents Basic Information
9.2.2 Boston Scientific Bioresorbable Drug-Eluting Stents Product Overview
9.2.3 Boston Scientific Bioresorbable Drug-Eluting Stents Product Market Performance
9.2.4 Boston Scientific Business Overview
9.2.5 Boston Scientific Bioresorbable Drug-Eluting Stents SWOT Analysis
9.2.6 Boston Scientific Recent Developments
9.3 Biotronik
9.3.1 Biotronik Bioresorbable Drug-Eluting Stents Basic Information
9.3.2 Biotronik Bioresorbable Drug-Eluting Stents Product Overview
9.3.3 Biotronik Bioresorbable Drug-Eluting Stents Product Market Performance
9.3.4 Biotronik Bioresorbable Drug-Eluting Stents SWOT Analysis
9.3.5 Biotronik Business Overview
9.3.6 Biotronik Recent Developments
9.4 Shanghai Bioheart Biological Technology
9.4.1 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Basic Information
9.4.2 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Overview
9.4.3 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Market Performance
9.4.4 Shanghai Bioheart Biological Technology Business Overview
9.4.5 Shanghai Bioheart Biological Technology Recent Developments
9.5 LifeTech Scientific
9.5.1 LifeTech Scientific Bioresorbable Drug-Eluting Stents Basic Information
9.5.2 LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Overview
9.5.3 LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Market Performance
9.5.4 LifeTech Scientific Business Overview
9.5.5 LifeTech Scientific Recent Developments
9.6 Lepu Medical Technology
9.6.1 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Basic Information
9.6.2 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Overview
9.6.3 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Market Performance
9.6.4 Lepu Medical Technology Business Overview
9.6.5 Lepu Medical Technology Recent Developments
9.7 Microport
9.7.1 Microport Bioresorbable Drug-Eluting Stents Basic Information
9.7.2 Microport Bioresorbable Drug-Eluting Stents Product Overview
9.7.3 Microport Bioresorbable Drug-Eluting Stents Product Market Performance
9.7.4 Microport Business Overview
9.7.5 Microport Recent Developments
9.8 Shandong Huaan Biotechnology
9.8.1 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Basic Information
9.8.2 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Overview
9.8.3 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Market Performance
9.8.4 Shandong Huaan Biotechnology Business Overview
9.8.5 Shandong Huaan Biotechnology Recent Developments
9.9 Shenzhen Salubris Biomedical Engineering
9.9.1 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Basic Information
9.9.2 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Overview
9.9.3 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Market Performance
9.9.4 Shenzhen Salubris Biomedical Engineering Business Overview
9.9.5 Shenzhen Salubris Biomedical Engineering Recent Developments
9.10 Beijing Advanced Medical Technologies
9.10.1 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Basic Information
9.10.2 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Overview
9.10.3 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Market Performance
9.10.4 Beijing Advanced Medical Technologies Business Overview
9.10.5 Beijing Advanced Medical Technologies Recent Developments
10 BIORESORBABLE DRUG-ELUTING STENTS MARKET FORECAST BY REGION
10.1 Global Bioresorbable Drug-Eluting Stents Market Size Forecast
10.2 Global Bioresorbable Drug-Eluting Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bioresorbable Drug-Eluting Stents Market Size Forecast by Country
10.2.3 Asia Pacific Bioresorbable Drug-Eluting Stents Market Size Forecast by Region
10.2.4 South America Bioresorbable Drug-Eluting Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bioresorbable Drug-Eluting Stents by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Bioresorbable Drug-Eluting Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bioresorbable Drug-Eluting Stents by Type (2025-2030)
11.1.2 Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bioresorbable Drug-Eluting Stents by Type (2025-2030)
11.2 Global Bioresorbable Drug-Eluting Stents Market Forecast by Application (2025-2030)
11.2.1 Global Bioresorbable Drug-Eluting Stents Sales (K Units) Forecast by Application
11.2.2 Global Bioresorbable Drug-Eluting Stents Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bioresorbable Drug-Eluting Stents Market Size Comparison by Region (M USD)
Table 5. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bioresorbable Drug-Eluting Stents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioresorbable Drug-Eluting Stents as of 2022)
Table 10. Global Market Bioresorbable Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bioresorbable Drug-Eluting Stents Sales Sites and Area Served
Table 12. Manufacturers Bioresorbable Drug-Eluting Stents Product Type
Table 13. Global Bioresorbable Drug-Eluting Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bioresorbable Drug-Eluting Stents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bioresorbable Drug-Eluting Stents Market Challenges
Table 22. Global Bioresorbable Drug-Eluting Stents Sales by Type (K Units)
Table 23. Global Bioresorbable Drug-Eluting Stents Market Size by Type (M USD)
Table 24. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Type (2019-2024)
Table 25. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2019-2024)
Table 26. Global Bioresorbable Drug-Eluting Stents Market Size (M USD) by Type (2019-2024)
Table 27. Global Bioresorbable Drug-Eluting Stents Market Size Share by Type (2019-2024)
Table 28. Global Bioresorbable Drug-Eluting Stents Price (USD/Unit) by Type (2019-2024)
Table 29. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Application
Table 30. Global Bioresorbable Drug-Eluting Stents Market Size by Application
Table 31. Global Bioresorbable Drug-Eluting Stents Sales by Application (2019-2024) & (K Units)
Table 32. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Table 33. Global Bioresorbable Drug-Eluting Stents Sales by Application (2019-2024) & (M USD)
Table 34. Global Bioresorbable Drug-Eluting Stents Market Share by Application (2019-2024)
Table 35. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Table 36. Global Bioresorbable Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 37. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Table 38. North America Bioresorbable Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 39. Europe Bioresorbable Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 41. South America Bioresorbable Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Bioresorbable Drug-Eluting Stents Basic Information
Table 44. Abbott Bioresorbable Drug-Eluting Stents Product Overview
Table 45. Abbott Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Bioresorbable Drug-Eluting Stents SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Boston Scientific Bioresorbable Drug-Eluting Stents Basic Information
Table 50. Boston Scientific Bioresorbable Drug-Eluting Stents Product Overview
Table 51. Boston Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boston Scientific Business Overview
Table 53. Boston Scientific Bioresorbable Drug-Eluting Stents SWOT Analysis
Table 54. Boston Scientific Recent Developments
Table 55. Biotronik Bioresorbable Drug-Eluting Stents Basic Information
Table 56. Biotronik Bioresorbable Drug-Eluting Stents Product Overview
Table 57. Biotronik Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biotronik Bioresorbable Drug-Eluting Stents SWOT Analysis
Table 59. Biotronik Business Overview
Table 60. Biotronik Recent Developments
Table 61. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Basic Information
Table 62. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Overview
Table 63. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Shanghai Bioheart Biological Technology Business Overview
Table 65. Shanghai Bioheart Biological Technology Recent Developments
Table 66. LifeTech Scientific Bioresorbable Drug-Eluting Stents Basic Information
Table 67. LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Overview
Table 68. LifeTech Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. LifeTech Scientific Business Overview
Table 70. LifeTech Scientific Recent Developments
Table 71. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Basic Information
Table 72. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Overview
Table 73. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lepu Medical Technology Business Overview
Table 75. Lepu Medical Technology Recent Developments
Table 76. Microport Bioresorbable Drug-Eluting Stents Basic Information
Table 77. Microport Bioresorbable Drug-Eluting Stents Product Overview
Table 78. Microport Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Microport Business Overview
Table 80. Microport Recent Developments
Table 81. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Basic Information
Table 82. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Overview
Table 83. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Shandong Huaan Biotechnology Business Overview
Table 85. Shandong Huaan Biotechnology Recent Developments
Table 86. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Basic Information
Table 87. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Overview
Table 88. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Shenzhen Salubris Biomedical Engineering Business Overview
Table 90. Shenzhen Salubris Biomedical Engineering Recent Developments
Table 91. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Basic Information
Table 92. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Overview
Table 93. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Beijing Advanced Medical Technologies Business Overview
Table 95. Beijing Advanced Medical Technologies Recent Developments
Table 96. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Bioresorbable Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Bioresorbable Drug-Eluting Stents Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Bioresorbable Drug-Eluting Stents Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Bioresorbable Drug-Eluting Stents Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bioresorbable Drug-Eluting Stents Market Size Comparison by Region (M USD)
Table 5. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Bioresorbable Drug-Eluting Stents Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioresorbable Drug-Eluting Stents as of 2022)
Table 10. Global Market Bioresorbable Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Bioresorbable Drug-Eluting Stents Sales Sites and Area Served
Table 12. Manufacturers Bioresorbable Drug-Eluting Stents Product Type
Table 13. Global Bioresorbable Drug-Eluting Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bioresorbable Drug-Eluting Stents
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bioresorbable Drug-Eluting Stents Market Challenges
Table 22. Global Bioresorbable Drug-Eluting Stents Sales by Type (K Units)
Table 23. Global Bioresorbable Drug-Eluting Stents Market Size by Type (M USD)
Table 24. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Type (2019-2024)
Table 25. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2019-2024)
Table 26. Global Bioresorbable Drug-Eluting Stents Market Size (M USD) by Type (2019-2024)
Table 27. Global Bioresorbable Drug-Eluting Stents Market Size Share by Type (2019-2024)
Table 28. Global Bioresorbable Drug-Eluting Stents Price (USD/Unit) by Type (2019-2024)
Table 29. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Application
Table 30. Global Bioresorbable Drug-Eluting Stents Market Size by Application
Table 31. Global Bioresorbable Drug-Eluting Stents Sales by Application (2019-2024) & (K Units)
Table 32. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Table 33. Global Bioresorbable Drug-Eluting Stents Sales by Application (2019-2024) & (M USD)
Table 34. Global Bioresorbable Drug-Eluting Stents Market Share by Application (2019-2024)
Table 35. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Table 36. Global Bioresorbable Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 37. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Table 38. North America Bioresorbable Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 39. Europe Bioresorbable Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 41. South America Bioresorbable Drug-Eluting Stents Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Bioresorbable Drug-Eluting Stents Basic Information
Table 44. Abbott Bioresorbable Drug-Eluting Stents Product Overview
Table 45. Abbott Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Bioresorbable Drug-Eluting Stents SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Boston Scientific Bioresorbable Drug-Eluting Stents Basic Information
Table 50. Boston Scientific Bioresorbable Drug-Eluting Stents Product Overview
Table 51. Boston Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boston Scientific Business Overview
Table 53. Boston Scientific Bioresorbable Drug-Eluting Stents SWOT Analysis
Table 54. Boston Scientific Recent Developments
Table 55. Biotronik Bioresorbable Drug-Eluting Stents Basic Information
Table 56. Biotronik Bioresorbable Drug-Eluting Stents Product Overview
Table 57. Biotronik Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biotronik Bioresorbable Drug-Eluting Stents SWOT Analysis
Table 59. Biotronik Business Overview
Table 60. Biotronik Recent Developments
Table 61. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Basic Information
Table 62. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Overview
Table 63. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Shanghai Bioheart Biological Technology Business Overview
Table 65. Shanghai Bioheart Biological Technology Recent Developments
Table 66. LifeTech Scientific Bioresorbable Drug-Eluting Stents Basic Information
Table 67. LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Overview
Table 68. LifeTech Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. LifeTech Scientific Business Overview
Table 70. LifeTech Scientific Recent Developments
Table 71. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Basic Information
Table 72. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Overview
Table 73. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lepu Medical Technology Business Overview
Table 75. Lepu Medical Technology Recent Developments
Table 76. Microport Bioresorbable Drug-Eluting Stents Basic Information
Table 77. Microport Bioresorbable Drug-Eluting Stents Product Overview
Table 78. Microport Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Microport Business Overview
Table 80. Microport Recent Developments
Table 81. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Basic Information
Table 82. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Overview
Table 83. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Shandong Huaan Biotechnology Business Overview
Table 85. Shandong Huaan Biotechnology Recent Developments
Table 86. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Basic Information
Table 87. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Overview
Table 88. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Shenzhen Salubris Biomedical Engineering Business Overview
Table 90. Shenzhen Salubris Biomedical Engineering Recent Developments
Table 91. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Basic Information
Table 92. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Overview
Table 93. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Beijing Advanced Medical Technologies Business Overview
Table 95. Beijing Advanced Medical Technologies Recent Developments
Table 96. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Bioresorbable Drug-Eluting Stents Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Bioresorbable Drug-Eluting Stents Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Bioresorbable Drug-Eluting Stents Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Bioresorbable Drug-Eluting Stents Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Bioresorbable Drug-Eluting Stents Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Bioresorbable Drug-Eluting Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bioresorbable Drug-Eluting Stents Market Size (M USD), 2019-2030
Figure 5. Global Bioresorbable Drug-Eluting Stents Market Size (M USD) (2019-2030)
Figure 6. Global Bioresorbable Drug-Eluting Stents Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bioresorbable Drug-Eluting Stents Market Size by Country (M USD)
Figure 11. Bioresorbable Drug-Eluting Stents Sales Share by Manufacturers in 2023
Figure 12. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers in 2023
Figure 13. Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bioresorbable Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bioresorbable Drug-Eluting Stents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bioresorbable Drug-Eluting Stents Market Share by Type
Figure 18. Sales Market Share of Bioresorbable Drug-Eluting Stents by Type (2019-2024)
Figure 19. Sales Market Share of Bioresorbable Drug-Eluting Stents by Type in 2023
Figure 20. Market Size Share of Bioresorbable Drug-Eluting Stents by Type (2019-2024)
Figure 21. Market Size Market Share of Bioresorbable Drug-Eluting Stents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bioresorbable Drug-Eluting Stents Market Share by Application
Figure 24. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Figure 25. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application in 2023
Figure 26. Global Bioresorbable Drug-Eluting Stents Market Share by Application (2019-2024)
Figure 27. Global Bioresorbable Drug-Eluting Stents Market Share by Application in 2023
Figure 28. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Figure 30. North America Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 32. U.S. Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Bioresorbable Drug-Eluting Stents Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Bioresorbable Drug-Eluting Stents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 37. Germany Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Bioresorbable Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Bioresorbable Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 44. China Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Bioresorbable Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 50. South America Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 51. Brazil Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bioresorbable Drug-Eluting Stents Market Share Forecast by Type (2025-2030)
Figure 65. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Application (2025-2030)
Figure 66. Global Bioresorbable Drug-Eluting Stents Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Bioresorbable Drug-Eluting Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bioresorbable Drug-Eluting Stents Market Size (M USD), 2019-2030
Figure 5. Global Bioresorbable Drug-Eluting Stents Market Size (M USD) (2019-2030)
Figure 6. Global Bioresorbable Drug-Eluting Stents Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bioresorbable Drug-Eluting Stents Market Size by Country (M USD)
Figure 11. Bioresorbable Drug-Eluting Stents Sales Share by Manufacturers in 2023
Figure 12. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers in 2023
Figure 13. Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bioresorbable Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bioresorbable Drug-Eluting Stents Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bioresorbable Drug-Eluting Stents Market Share by Type
Figure 18. Sales Market Share of Bioresorbable Drug-Eluting Stents by Type (2019-2024)
Figure 19. Sales Market Share of Bioresorbable Drug-Eluting Stents by Type in 2023
Figure 20. Market Size Share of Bioresorbable Drug-Eluting Stents by Type (2019-2024)
Figure 21. Market Size Market Share of Bioresorbable Drug-Eluting Stents by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bioresorbable Drug-Eluting Stents Market Share by Application
Figure 24. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2019-2024)
Figure 25. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application in 2023
Figure 26. Global Bioresorbable Drug-Eluting Stents Market Share by Application (2019-2024)
Figure 27. Global Bioresorbable Drug-Eluting Stents Market Share by Application in 2023
Figure 28. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
Figure 29. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2019-2024)
Figure 30. North America Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 32. U.S. Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Bioresorbable Drug-Eluting Stents Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Bioresorbable Drug-Eluting Stents Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 37. Germany Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Bioresorbable Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Bioresorbable Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 44. China Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Bioresorbable Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 50. South America Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2023
Figure 51. Brazil Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Bioresorbable Drug-Eluting Stents Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Bioresorbable Drug-Eluting Stents Market Share Forecast by Type (2025-2030)
Figure 65. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Application (2025-2030)
Figure 66. Global Bioresorbable Drug-Eluting Stents Market Share Forecast by Application (2025-2030)
